Episodes
In this educational activity, faculty discuss current and emerging strategies for diagnosis and management of meibomian gland dysfunction and associated conditions.
Published 12/21/22
In this educational activity, faculty discuss recent developments in ocular surface disease presented at the Fall 2022 academic conferences.
Published 12/21/22
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with uveitis.
Published 10/19/22
In this podcast, expert clinicians will discuss the utilization of surgery in the management of patients with retinal diseases.
Published 10/19/22
In this podcast, expert clinicians will discuss the utilization of imaging in patients with retinal diseases.
Published 10/19/22
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with retinal vein occlusion.
Published 10/19/22
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with neovascular age-related macular degeneration, dry age-related macular degeneration, and geographic atrophy.
Published 10/19/22
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with diabetic eye disease.
Published 10/19/22
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular...
Published 05/31/22
Targeting Angiopoietin-2 in nAMD: Efficacy and Safety Data With Drs. Carl Regillo and Arshad Khanani
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular...
Published 05/31/22
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular...
Published 05/31/22
Steven Ferrucci, OD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 4.
Published 05/10/22
Rishi P. Singh, MD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 3.
Published 05/10/22
Steven Ferrucci, OD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 2.
Published 05/10/22
Rishi P. Singh, MD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 1.
Published 05/10/22
In this podcast, expert clinicians will discuss best practices for reducing ocular toxicities in myeloma patients through the multidisciplinary team.
Published 01/31/22
In this podcast, expert clinicians will discuss strategies to mitigate and manage ocular toxicities related to multiple myeloma therapy.
Published 01/31/22
In this podcast, expert clinicians will discuss the frequency and identification of ocular toxicities of patients on myeloma therapy.
Published 01/31/22
In this podcast, expert clinicians will discuss the mechanisms behind ocular toxicities that have been associated with antibody drug conjugates used for cancer treatment.
Published 01/31/22
This educational activity will review best practices regarding the use of gel stents in the treatment of glaucoma.
Published 12/28/21
In this podcast, John Samples, MD, and Brian Francis, MD, discuss the current and evolving role of optical coherence tomography angiography in the management of glaucoma.
Published 12/16/21
In this podcast, John Samples, MD, and Michael Giovigno, MD, review best practices for the use of cyclophotocoagulation in the management of glaucoma.
Published 12/16/21
In this podcast, John R. Samples, MD, and Russell Swan, MD, discuss the relevance of cerebrospinal fluid pressure in the management of glaucoma.
Published 12/16/21
This educational activity will review best practices in the management of patients with glaucoma.
Published 11/09/21
Recap with Dr. Rishi Singh: An Overview of Intravitreal Interventions Volume 10, Issue 4
Published 09/27/21
Listen now
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
